Abstract
The ECG QTc interval was significantly prolonged by pimozide but not haloperidol or placebo in a randomized clinical trial with 40 patients with Tourette's disorder. However, no adverse cardiac effects or differences in rate, rhythm, or waveform were found.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 673-675 |
| Number of pages | 3 |
| Journal | American Journal of Psychiatry |
| Volume | 144 |
| Issue number | 5 |
| DOIs | |
| State | Published - 1987 |
ASJC Scopus subject areas
- Psychiatry and Mental health
Fingerprint
Dive into the research topics of 'ECG changes during haloperidol and pimozide treatment of Tourette's disorder'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS